Citius Pharmaceuticals Inc (CTXR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -15,562 | -11,912 | -7,507 | -3,875 | -12,537 |
| Depreciation Amortization | 1 | 1 | 1 | 0 | 2 |
| Accounts payable and accrued liabilities | 1,140 | 857 | 353 | 510 | 971 |
| Other Working Capital | 2,196 | 1,685 | 1,006 | 1,545 | 510 |
| Other Operating Activity | -213 | -161 | 140 | -339 | -264 |
| Operating Cash Flow | $-12,438 | $-9,531 | $-6,008 | $-2,159 | $-11,318 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 11,148 | 4,857 | 23 | 16 | 17,298 |
| Financing Cash Flow | $11,148 | $4,857 | $23 | $16 | $17,298 |
| Beginning Cash Position | 9,184 | 9,184 | 9,184 | 9,184 | 3,204 |
| End Cash Position | 7,894 | 4,511 | 3,199 | 7,042 | 9,184 |
| Net Cash Flow | $-1,290 | $-4,673 | $-5,985 | $-2,143 | $5,980 |
| Free Cash Flow | |||||
| Operating Cash Flow | -12,438 | -9,531 | -6,008 | -2,159 | -11,318 |
| Free Cash Flow | -12,438 | -9,531 | -6,008 | -2,159 | -11,318 |